title: Symptomatic BK virus reactivation following fludarabine, cyclophosphamide and rituximab chemotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma.
authors.affiliation: Haematology.
authors.forename: Niamh
authors.initials: N
authors.lastname: Appleby
authors.forename: Anna
authors.initials: A
authors.lastname: Dillon
authors.forename: Martin
authors.initials: M
authors.lastname: Arrigan
authors.forename: Jerome
authors.initials: J
authors.lastname: Fennell
authors.forename: Brendan
authors.initials: B
authors.lastname: Crowley
authors.forename: Patrick J
authors.initials: PJ
authors.lastname: Hayden
authors.forename: Helen
authors.initials: H
authors.lastname: Enright
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001739:BK Virus / Q000187:drug effects / Q000502:physiology*; D003556:Cystitis / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology*; D008297:Male; D008875:Middle Aged; D027601:Polyomavirus Infections / Q000821:virology*; D016896:Treatment Outcome; D014412:Tumor Virus Infections / Q000821:virology*; D014775:Virus Activation / Q000187:drug effects